EMA Explains When 'Out Of Specification' CAR-Ts Can Be Given To Patients
Executive Summary
The European Medicines Agency must be informed about each 'out of specification' batch of a cell or tissue-based advanced therapy that has been granted marketing authorization. The agency warns that if a trend is discovered, it may consider the need for regulatory actions.